UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fomento Económico Mexicano
FMX
$43.6B
| $73.6M | 0.07% |
825,600
+12,700
| +2% | +$1.18M |
|
302
Illumina
ILMN
$31B
| $73.1M | 0.07% |
344,297
+1,737
| +0.5% | +$339K |
|
303
WEC Energy
WEC
$35.7B
| $73M | 0.07% |
1,621,406
+118,934
| +8% | +$5.71M |
|
304
International Paper
IP
$21.6B
| $72.8M | 0.07% |
1,616,235
+73,521
| +5% | +$3.65M |
|
305
Brookfield
BN
$104B
| $72.8M | 0.07% |
5,933,509
+54,727
| +0.9% | +$697K |
|
306
Analog Devices
ADI
$179B
| $71.8M | 0.07% |
1,119,196
-10,556
| -0.9% | -$685K |
|
307
Newmont
NEM
$98.7B
| $71.8M | 0.07% |
3,072,909
-14,003
| -0.5% | -$350K |
|
|
SIAL
308
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $71.6M | 0.07% |
514,025
+103,056
| +25% | +$14.3M |
|
|
TYC
309
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $71.2M | 0.07% |
1,766,530
+107,366
| +6% | +$4.58M |
|
|
STJ
310
DELISTED
St Jude Medical
STJ
| $70.9M | 0.07% |
970,132
+490
| +0.1% | +$35.4K |
|
|
SNDK
311
DELISTED
SANDISK CORP
SNDK
| $70.6M | 0.07% |
1,212,626
+240,237
| +25% | +$16.1M |
|
|
HOUS
312
DELISTED
Anywhere Real Estate
HOUS
| $70.3M | 0.07% |
1,505,244
+1,180,602
| +364% | +$54.9M |
|
|
RAD
313
DELISTED
Rite Aid Corporation
RAD
| $70.1M | 0.07% |
419,612
+70,267
| +20% | +$11.8M |
|
314
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $69.8M | 0.07% |
339,184
+51,519
| +18% | +$10.8M |
|
315
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $69.1M | 0.07% |
1,690,811
+48,682
| +3% | +$2.09M |
|
316
The Mosaic Company
MOS
$7.03B
| $68.5M | 0.07% |
1,461,485
+111,790
| +8% | +$5.07M |
|
317
Quest Diagnostics
DGX
$25.7B
| $68.4M | 0.07% |
943,844
+65,941
| +8% | +$4.87M |
|
318
Ingredion
INGR
$6.27B
| $68.1M | 0.07% |
853,303
+357,492
| +72% | +$28.7M |
|
319
Entergy
ETR
$50.2B
| $67.9M | 0.07% |
1,925,952
+57,838
| +3% | +$2.17M |
|
320
Edison International
EIX
$28.2B
| $67.6M | 0.06% |
1,216,882
+19,666
| +2% | +$1.18M |
|
321
W.W. Grainger
GWW
$65.3B
| $67.3M | 0.06% |
284,577
+23,384
| +9% | +$5.67M |
|
322
Franklin Resources
BEN
$17.6B
| $67.2M | 0.06% |
1,370,338
+5,372
| +0.4% | +$276K |
|
323
Bath & Body Works
BBWI
$4.06B
| $66.8M | 0.06% |
964,110
+634
| +0.1% | +$45.5K |
|
|
CMCSK
324
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $66.8M | 0.06% |
1,114,499
-6,854
| -0.6% | -$411K |
|
325
Fidelity National Information Services
FIS
$23.1B
| $66.7M | 0.06% |
1,079,664
-23,924
| -2% | -$1.53M |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.